CONVENTIONAL-DOSE VERSUS HIGH BOSE POSTREMISSION THERAPY FOR ADULTS WITH LYMPHOBLASTIC LYMPHOMA - A PROGRESS REPORT ON THE EBMT UKLG TRIAL ARID A PRELIMINARY-ANALYSIS OF PROGNOSTIC FACTORS/

Authors
SWEETENHAM JW SANTINI G SIMNETT S GIBSON D GUELFI M BRUZZI P MACHIN D GOLDSTONE AH
Citation
Jw. Sweetenham et al., CONVENTIONAL-DOSE VERSUS HIGH BOSE POSTREMISSION THERAPY FOR ADULTS WITH LYMPHOBLASTIC LYMPHOMA - A PROGRESS REPORT ON THE EBMT UKLG TRIAL ARID A PRELIMINARY-ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 88(10), 1996, pp. 484-484
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
1
Supplement
1
Pages
484 - 484
Database
ISI
SICI code
0006-4971(1996)88:10<484:CVHBPT>2.0.ZU;2-9